It appears that increased circulating irisin levels are positively associated with BMI and fat mass because compensatory elevated irisin levels act as an anti-obese property to combat metabolic disorders such as obesity, MS, and insulin resistance [16,17,32]. This evidence concerns the gene FNDC5 and obesity due to melanocortin 4 receptor deficiency.